Inogen to Provide Strategy Update on February 27, 2023
Inogen, Inc. (Nasdaq: INGN), a medical technology company specializing in respiratory products, will host a conference call on February 27, 2023, at 10:00 a.m. Eastern Time. President and CEO Nabil Shabshab and CFO Kristin Caltrider will discuss the company's commercial and innovation strategies. A live audio webcast and archived recording will be available on Inogen's Investor Relations website. Inogen aims to enhance patient respiratory care through innovative portable oxygen concentrators, partnering with various healthcare stakeholders to ensure accessibility and mobility for patients suffering from chronic respiratory conditions.
- Hosting a conference call to discuss commercial and innovation strategies.
- Focus on enhancing patient respiratory care with innovative products.
- None.
A live audio webcast and archived recording of the presentation will be available to all interested parties through the News / Events page on the Inogen Investor Relations website.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
About Inogen
For more information, please visit www.inogen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230223005533/en/
ir@inogen.net
Source:
FAQ
What is the date and time of Inogen's upcoming conference call?
Who will be speaking at Inogen's conference call?
Where can I access the live audio webcast of Inogen's conference call?